ArticlePulmonary circulation2022

Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension.

Yuichi Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.